IDDI, Biostatistical and eClinical Services for Clinical Trials

TRIAL DESIGN - RANDOMIZATION - DATA MANAGEMENT - BIOSTATISTICS
Twitter icon
Facebook icon
LinkedIn icon
Google+ icon
YouTube icon
RSS icon

Secondary menu

Home > News > News > Meet IDDI Oncology Experts At ASCO Annual Conference

Meet IDDI Oncology Experts At ASCO Annual Conference

Archives

June 2, 2017 to June 7, 2017

Meet IDDI Oncology Experts
At ASCO Conference

June 2-6, 2017  -  Chicago, Illinois: McCormick Place

 

IDDI is an oncology CRO led by a highly-skilled biostatistical and clinical team of thought-leaders in oncology research. IDDI  combines advanced biostatistics, regulatory and medical expertise, and innovative integrated eClinical solutions to increase efficiency and mitigate risks throughout the drug development process.

 


Our valuable therapeutic insight in cancer research, paired with data quality expertise, will make a critical difference to the outcome of your clinical trials. 
 

Leverage Our Oncology Expertise And Gain Efficiency In Your Oncology Trials​

IDDI’s expertise lies in the right choice of endpoints, adequate definition of selection criteria and state-of-the-art statistical planning, and analysis and modelling tailored to oncology drug development needs.​ The IDDI Clinical Development Team provides high-level clinical, statistical and regulatory services to optimize your clinical development strategy. At IDDI we develop innovative strategies and have the focused capabilities needed to launch products with the greatest potential for commercial success and patient outcomes.

 

580+
ONCOLOGY STUDIES  
12 FDA/EMA APPROVALS 
IN ANTI-CANCER THERAPIES 
       66%
STUDIES
IN ONCOLOGY

                    

Meet our Oncology Experts At ASCO Meeting

 

Marc Buyse ScD Chief Scientific Officer, Founder IDDI
Marc Buyse holds a ScD in biostatistics from the Harvard School of Public Health (Boston, MA). He is the founder of the International Drug Development Institute (IDDI) and of CluePoints, two biostatistical service organizations based in the US and Europe. He is interested in clinical trial design, meta-analysis, validation of biomarkers and surrogate endpoints, statistical methods in oncology, statistical detection of errors and fraud, statistical monitoring of clinical trials, and medical data sharing ​​

 

 

 

 

Everardo Saad, MD Medical Director IDDI
Dr. Saad has over 15 years of experience in Medical Oncology and clinical trial designs. He graduated in Medicine and trained in Internal Medicine in Sao Paulo, and did his fellowship in Medical Oncology at the University of Texas M.D. Anderson Cancer Center, in Houston. After practicing for several years, he shifted his professional career towards education and research in Medical Oncology, and has a special interest in clinical trial methodology, the assessment of endpoints, and the development of novel therapies for cancer patients.​

 

Looking forward to meeting you at ASCO! ​